LP
MDLN

Longaeva Partners’s Medline Inc MDLN Stock Holding History

Longaeva Partners’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.3M Buy
635,000
+544,762
+604% +$24.1M 1.05% 24
2025
Q4 		$3.79M Buy
+90,238
New +$3.81M 0.32% 74

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Longaeva Partners's MDLN Position: Q1 2026 in Review

Longaeva Partners increased its Medline Inc (MDLN) stake by 604% in Q1 2026, buying an estimated $24.1M and bringing the position to 635,000 shares worth $28.3M. The position accounts for 1.05% of the portfolio, ranked #24.

Longaeva Partners first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Longaeva Partners held 635,000 shares of Medline Inc worth $28.3M as of Q1 2026.
  • Longaeva Partners bought 544,762 Medline Inc shares in Q1 2026, an estimated $24.1M.
  • Medline Inc made up 1.05% of Longaeva Partners's portfolio in Q1 2026, its #24 holding.
  • Longaeva Partners first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Longaeva Partners's 13F filing for Q1 2026, filed 15 May 2026.